Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
41 Cards in this Set
- Front
- Back
brompheniramine
|
first gen H1 blocker, anticholinergic activity
IN GENERAL of 1st gen H1 blockers: rapidly absorbed when taken orally distributes to most tissues 4-6 hrs duration of action clinical use: allergic reactions - hay fever, urticaria, not utilized for bronchial asthma motion sickness- prevention rather than tx, sedative effects, diphenhydramine>cyclizine and meclizine local anesthetic action - Na channel blockers, diphenhydramine and promethazine are more potent than procaine as local anesthetics others: antiparkinsonian, anticholinergic, adrenergic-blocking, serotonin-blocking side effects: slight sedation, anti-muscarinic - urinary retention, blurred vision interactions: cyp450 inhibition (antifungals), think about sedation when giving other CNS depressants |
|
chlorpheniramine
|
first gen H1 blocker, anticholinergic activity
side effects: slight sedation, common component of OTC cold meds |
|
clemastine
|
first gen H1 blocker
|
|
cyclizine
|
first gen H1 blocker, anticholinergic activity
side effects: slight sedation effects: anti-motion sickness activity |
|
cypropheptadine
|
first gen H1 blocker
|
|
dexchlorpheniramine
|
first gen H1 blocker
|
|
dimenhydrinate
|
first gen H1 blocker, anticholinergic activity
side effects: marked sedation effects: anti-motion sickness activity |
|
diphenhydramine
|
first gen H1 blocker
|
|
hydroxyzine
|
first gen H1 blocker
|
|
meclizine
|
first gen H1 blocker
|
|
promethazine
|
first generation H1 blocker, anticholinergic activity;
marked sedation, antiemetic, block |
|
cetirizine
|
2nd generation H1 blocker, no anticholinergic effects
in general: 12-24 hours duration of action effects: allergic reactions - allergic rhinitis and urticaria, not utilized for bronchial asthma motion sickness - prevention rather than treatment, sedative effects: diphenhydramine > cyclizine and meclizine local anesthetic action - Na channel blockers, diphenhydramine and prometazine are more potent than procaine as local anesthetics other effects: antiparkinsonian, anticholinergic, adrenergic blocking, serotonin blocking toxicity: sedation drug interactions: cyp450 inhibition (anti-fungals), sedation effect - addnl consideration when given w/ other CNS depressants |
|
desloratadine
|
2nd generation H1 blocker, no anticholinergic effects
|
|
fexofenadine
|
2nd generation H1 blocker, no anticholinergic effects
|
|
loratadine
|
2nd generation H1 blocker, no anticholinergic effects
longer action |
|
azelastine
|
2nd generation H1 blocker, no anticholinergic effects
|
|
cimetidine
|
H2 blockers
effects: reducing gastric acid secretion - peptic ulcer, GERD, other hypersecretory diseases little effect on cardiac fxn, intestinal secretion |
|
famotidine
|
H2 blockers
effects: reducing gastric acid secretion - peptic ulcer, GERD, other hypersecretory diseases little effect on cardiac fxn, intestinal secretion |
|
nizatidine
|
H2 blockers
effects: reducing gastric acid secretion - peptic ulcer, GERD, other hypersecretory diseases little effect on cardiac fxn, intestinal secretion |
|
ranitidine
|
H2 blockers
effects: reducing gastric acid secretion - peptic ulcer, GERD, other hypersecretory diseases little effect on cardiac fxn, intestinal secretion |
|
cromolyn
|
histamine release inhibitors
|
|
nedocromil
|
histamine release inhibitors
|
|
buspirone
|
5-HT receptor agonist
5-HT1A partial agonist non-benzodiazepine anxiolytic |
|
fenfluramine
|
5-HT receptor agonist
5-HT4 agonist |
|
dexfenfluramine
|
5-HT receptor agonist
5-HT4 agonist 5-HT2C agonist - appetite suppression, withdrawn due to toxicity |
|
cisapride
|
5-HT receptor agonist
5-HT4 agonist used for the treatment of GERD and motility disorders available for compassionate use |
|
almotriptan
|
selective 5-HT1D and 5-HT1B receptor agonists
other -triptans as well!!! effects: counteracts vasodilating peptide calcitonin gene-related peptide (CGRP) constrict cerebral and meningeal vessels in tx acute migraines efficacy aginst migraine similar to other classes of drugs side effects: tingling and warmth sensations, dizziness, muscle weakness, neck pain, chest discomfort (vasospasm, angina) |
|
phenoxybenzamine
|
non-selective 5-HT antagonists
5-HT2 antagonist - long acting!! (irreversible (and alpha-adrenergic receptors) |
|
cyproheptadine
|
5-HT2 antagonist and H1 receptor antagonist
useful for the smooth muscle effects of carcinoid tumors serotonin syndrome treatment |
|
ondansetron
|
5-HT3 receptor antagonists
other -setrons as well! used for treatment of nausea/vomiting in cancer chemo |
|
dihydroergotamine
|
nonselective 5-HT agonists
limited 5-HT effects preferred for the treatment of migraine side effects IN GENERAL: nausea, vomiting, diarrhea due to increased GIT motility resulting from activation of 5-HT receptors in the CNS and GIT most serious toxic effect - prolonged vasospasm in the arms/legs, may cause gangrene and amputation drowsiness and hallucinations occur infrequently |
|
ergonovine
|
nonselective 5-HT agonists
most selective for the uterus, if oxytocin fails, is utilized to limit post-partum hemorrhage |
|
ergotamine mixtures
|
nonselective 5-HT agonists
|
|
ergotamine tartrate
|
nonselective 5-HT agonists
|
|
methylergonovine
|
nonselective 5-HT agonists
|
|
lysergic acid diethylamine (LSD)
|
nonselective 5-HT agonists
powerful hallucinogen |
|
ergotamine
|
nonselective 5-HT agonists
potent vasoconstrictor |
|
ergocryptime
|
nonselective 5-HT agonists
|
|
bromocriptine
|
nonselective 5-HT agonists
in general: agonists, partial agonists, and antagonists at diverse receptors - alpha adrenergic receptors, 5-HT1A and ID > 5-HT2 and HT3, central dopamine receptors act at both pre and post-synaptic sites effects: CNS - selectivity for pituitary dopamine receptors, suppress prolactin secretion, useful in tx pit tumor |
|
cabergoline
|
nonselective 5-HT agonists
effects: selective for pituitary dopamine receptors, suppress prolactin secretion, useful in tx pituitary tumor |
|
tegaserod
|
partial 5-HT4 agonist
utilized for IBS with constipation |